Catechin-containing medicament composition and application of catechin-containing medicament composition in preparation of medicament for treating leukemia

Abstract

The invention discloses a catechin-containing medicament composition and application of the catechin-containing medicament composition in preparation of a medicament for treating leukemia. The medicament composition basically consists of the following components in parts by weight: 6-8 parts of catechin, 6-8 parts of saffron crocus, 4-5 parts of androsace umbellate, 2-4 parts of selaginella uncinata, 1-2 parts of thyme, 1-2 parts of sarcandra glabra, 1-2 parts of zornia diphylla pers, 1-2 parts of felwort, 1-2 parts of polygonum perfoliatum and 1-2 parts of tadehagi triquetrum. According to the catechin-containing medicament composition, the catechin is used as a main component of the composition, and a proper amount of the saffron crocus component is added, so that the DNA synthetase system of leukemia cells can be damaged, and the effect of preventing and treating leukemia is achieved; meanwhile, by adding of the components such as the androsace umbellate, selaginella uncinata, thyme, sarcandra glabra, zornia diphylla pers, felwort, polygonum perfoliatum and tadehagi triquetrum, multiplication of the leukemia cells is further suppressed, and the medicament working speed is increased. By reasonable material selection and reasonable use amounts, an outstanding technical effect is achieved; meanwhile, the catechin-containing medicament composition is low in cost and easy to realize, and has an outstanding popularization prospect.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to View More

AI Technical Summary

Benefits of technology

This patented technology uses certain chemical agents called chlorophyll or quinone-oxide (QO) that can kill cancerous white blood cell lines without harming healthy ones' own red blood cells. These chemotherapy treatments help improve patient survival rates while also reducing their risk for developing recurrence after therapies like radiation/chemotherapy.

Problems solved by technology

The technical problem addressed by this patents relates to developing effective therapies for lymphoma without causing harmful side effects such as bleeding from multiple sources, including chemo/chemodynamic agents, radiation exposures, immunosuppressants, cytokines, growth factor blockers like LHBP1A2, TGFβR agonists, IL-17 family members, antibiosis against tumor cell lines, and various types of cancer related diseases caused by abnormalities during these processes.

Images